McKinsey's Opioid Woes Far From Over Despite $600M Deals
Plaintiffs lawyers who spearheaded opioid litigation against pharmaceutical companies are opening a new front against McKinsey & Co. on behalf of local governments, indicating that the consulting giant's settlements worth $600...To view the full article, register now.
Already a subscriber? Click here to view full article